The BioSense Program provides local, state, and federal partners a timely regional and national picture of trends in disease syndromes and situation awareness. BioSense is in the midst of a redesign that shifts the program's focus to meet the needs of stakeholders and end users in state and local health departments, CDC programs, hospitals, and other federal programs (i.e. DoD and VA) to improve regional and national coverage.
We invite all
interested stakeholders to join the BioSense Collaboration Site (centerpiece
of the redesign). This site is the quickest way to get information about the
redesigned program and features interactive elements designed to foster and encourage transparent information exchange and allow stakeholders to: (1) follow the BioSense Redesign project as it progresses; (2) provide input; and (3) communicate and exchange ideas with one another and with the BioSense Redesign team.
BioSense is undergoing a redesign to improve features such as centralized data mining at a "distant" federal facility and address concerns that the system could not meet its objective to provide early warning or detect local outbreaks (i.e., 2001 anthrax outbreak). The redesign will also address challenges with false alarms and associated costs to resource-strapped state and local health departments in response to externally generated false alerts.
With input and
guidance from local, state, and federal partners, the Centers for Disease
Control and Prevention (CDC)’s Office of Surveillance, Epidemiology, and
Laboratory Services (OSELS) is working with RTI International to redesign the BioSense
Program. RTI (working under CDC contract number GS10F0097L) is an independent,
nonprofit research institute providing research and technical expertise to
governments and businesses in health and pharmaceuticals, surveys and
statistics, advanced technology, and other services and areas. For more
information, visit www.rti.org.
The goal of the redesign and redirection effort is to be able to provide nationwide and regional situation awareness for all-hazard health threats (beyond bioterrorism) and to support national, state, and local responses to those threats. By
integrating local and state-level data into a cohesive “picture,”
improve its utility for state and local stakeholders and provide multipurpose
timely data for regional (i.e., multistate) and national view of
health outcomes and syndromes. This will be accomplished through inclusion of more jurisdictions and distributed ED coverage across the US.
The focus of the redesign is to:
The key components of the BioSense program redesign include:
Activities planned for the redesign process include the following: